Author

D. Mu

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Carr· 1 shared C. Gao· 1 shared C. Liu· 1 shared D. Kong· 1 shared H. Lou· 1 shared J. Chen· 1 shared M. Zeng· 1 shared P. Yue· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Carr

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Synthetic lethality between TP53 and ENDOD1

Z. Tang, M. Zeng, X. Wang, C. Gao, P. Yue, X. Zang, H. Lou, J. Chen, D. Mu, D. Kong, A. Carr, C. Liu

This study identifies synthetic lethality between ENDOD1 and TP53, showing that their combined loss causes DNA damage and cell death, suggesting ENDOD1 as a cancer therapeutic target.

bioRxiv · Oct 14, 2020Cancer Biology